Fulcrum Therapeutics Inc (FULC) is trading up at $3.85 (+0.26%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Fulcrum (FULC) is Allocating 95% of the Combined Company to Slate and PIPE Investors. Is the $270M Dividend Enough?
Fulcrum (FULC) is Allocating 95% of the Combined Company to Slate and PIPE Investors. Is the $270M Dividend Enough?